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Abstract—A common challenge of many scientific studies is to
determine whether a treatment is effective for an outcome. When
considering a binary treatment, this problem can be addressed
by estimating the average treatment effect using the potential
outcome framework. Moreover, since different individuals often
respond differently to the same treatment due to their dis-
tinct characteristics. In order to understand the heterogeneous
treatment effect for different individuals, practitioners need to
estimate the conditional average treatment effects conditioning on
the variables describing the distinct characteristics of individuals.
Much research has been devoted to the estimation of treatment
effects from observational data; however, most of them assume
that the set of observed variables contains exactly all the
confounders that affect both the treatment and the outcome. Un-
fortunately, this assumption is frequently violated in real-world
applications not only because some of the observed variables
only affect the treatment or the outcome, but also due to the fact
that in many cases only the proxy variables of the underlying
confounding factors can be observed. In this work, we first
show the importance of differentiating confounding factors from
instrumental and risk factors for average and conditional average
treatment effect estimation, and then we propose a variational
inference approach to simultaneously infer latent factors from
the observed variables and disentangle the factors into three
disjoint sets corresponding to the instrumental, confounding, and
risk factors. Experimental results demonstrate the effectiveness
of the proposed method on synthetic, benchmark, and real-world
datasets for treatment effect estimation.
Index Terms—treatment effect estimation, observational data,
neural network, generative model.
I. INTRODUCTION
A fundamental challenge faced by many scientific re-
searchers is whether and to what degree a treatment would
affect an outcome at both population and individual level.
When a binary treatment is considered, the problem become
how to estimate the average treatment effect (ATE) and the
conditional average treatment effect (CATE). Treatment effect
estimation has a have wide range of applications across
diverse disciplines. In social economy, policy makers need
to determine whether a job training program will improve
the employment perspective of the workers [1]. In cancer
diagnosis, oncologists need to determine whether prescribing
radiotherapy will improve the prognosis of a particular pa-
tient [2]. In online advertisement, companies need to predict
whether an advertisement campaign could persuade a potential
buyer into buying the product [3].
In the center of these questions lies the counterfactual prob-
lem: each subject is associated with two potential outcomes:
the treated outcome (the factual outcome) if the subject had
received the treatment and the control outcome if the subject
had not, i.e. had received the control. Once a subject has been
assigned to the treatment, it is impossible to know what the
potential outcome would have been had the subject received
the control (the counterfactual outcome), and vice versa. Since
the underlying ground truth treatment effect is defined by
both the factual and counterfactual outcomes, estimation of
treatment effect is difficult in observational studies without
additional assumptions [4].
To enable the estimation of treatment effect from observa-
tional data, the treatment assignment mechanism needs to be
independent of the possible outcomes when conditioned on the
observed variables, i.e., the unconfoundedness assumption [5]
needs to be satisfied. With this assumption, treatment effects
can be estimated from observational data by adjusting on
the confounding variables which affects both the treatment
assignment and the outcome. If not all the confounders are
measured and considered in the estimation, the treatment effect
estimation may be biased [6].
From a theoretical perspective, practitioners are tempted
to include as many variables as they can for confounding
adjustment to ensure the satisfaction of the unconfoundedness
assumption. This is because confounders can be difficult to
measure in the real-world and practitioners need to include
noisy proxy variables to ensure unconfoundedness. For exam-
ple, the socio-economic status of patients confounds treatment
and prognosis, but cannot be included in the electronic medical
records due to privacy concerns. Luckily, it is often the case
that such unmeasured confounders can be inferred from noisy
proxy variables which are easier to measure. For instance, the
zip codes and job types of the patients can be used as proxies
to infer their socio-economic statuses [7].
From a practical perspective, the inflated number of vari-
ables included for confounding adjustment reduces the ef-
ficiency of treatment effect estimation. Moreover, it has
been previously shown that including unnecessary covariates
is suboptimal when the treatment effect is estimated non-
parametrically [4], [8], [9]. In a high dimensional scenario,
eventually many included variables will not be confounders
and should be excluded from the set of adjustment variables.
Other than irrelevant variables that are not related to either
the treatment or the outcome, the observed variables can
be categorized into three groups. The first group contains
ar
X
iv
:2
00
1.
10
65
2v
2 
 [c
s.L
G]
  1
4 J
ul 
20
20
instrumental variables that are related to the treatment, but
has no effect on the outcome. The second category contains
confounding variables that affect both the treatment and the
outcome, and the third group of variables are the risk factors
that only affect the outcome but not the treatment.
Most existing treatment estimation algorithms treat the
given variables “as is”, and leave the daunting task of choosing
confounding adjustment variables to the users. It is clear
that the users are left with a dilemma: on the one hand
including more variables than necessary produces inefficient
and inaccurate estimators; on the other hand restricting the
number of adjustment variables may exclude confounders
themselves or proxy variables of the confounders and thus
increases the bias of the estimated treatment effects. With
only a handful of variables, the problem can be avoided by
consulting domain experts. However, a data-driven approach
is required in the big data era to deal with the dilemma.
In this work, we propose a data-driven approach for si-
multaneously inferencing latent factors from proxy variables
and disentangling the learned factors into three disjoint sets
as illustrated in Figure 1: the instrumental factors zt which
only affect the treatment but not the outcome, the risk factors
zy which only affect the outcome but not the treatment,
and the confounding factors zc that affect both the treatment
and the outcome. Since our method builds upon the recent
advancement of the research on variational autoencoder [10],
we name our method Treatment Effect by Disentangled Vari-
ational AutoEncoder (TEDVAE). Our main contributions are:
• We address a new problem in treatment effect estimation
using observational data in the real-world scenario, in the
presence of noisy proxies and non-confounders, which
is critical for designing efficient and accurate estimators
from observational data in the big data era.
• We propose a data-driven algorithm, TEDVAE, to si-
multaneously infer latent factors from proxy variables
and disentangle confounding factors from the others for
efficient estimation of the treatment effects.
• We validate the effectiveness of the proposed TEDVAE
algorithm on a wide range of synthetic datasets, treatment
effect estimation benchmarks and real-world datasets. The
results show that TEDVAE outperforms existing state-of-
the-art algorithms and is not sensitive to parameters.
The rest of this paper is organized as follows. In Section
II, we review related work on treatment effect estimation. The
details of our methods is presented in Section III. In Section
IV, we discuss the evaluation metrics, datasets and experiment
results. Finally, we conclude the paper in Section V.
II. RELATED WORK
Estimation of the causal effects a treatment has steadily
drawn the attentions of researchers from the statistics and
machine learning communities. During the past decade, several
tree based methods [1], [2], [11], [12] have been proposed
to address the problem by designing a treatment effect spe-
cific splitting criterion for recursive partitioning. Ensemble
algorithms and meta algorithms [13], [14] have also been
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Fig. 1: Model diagram for the proposed Treatment Effect with
Disentangled Autoencoder (TEDVAE). t is the treatment, y
is the outcome. x is the “as-is” observed variables which
may contain non-confounders and noisy proxy variables. zt
are factors that affect only the treatment, zy are factors that
affect only the outcome, and zc are confounding factors that
affect both treatment and outcome.
explored. For example, Causal Forest [14] builds ensembles
using the Causal Tree [1] as base learners. X-Learner [13] is
a meta algorithm that can utilize off-the-shelf machine learning
algorithms for treatment effect estimation.
Deep learning based heterogeneous treatment effect estima-
tion methods have attracted increasingly research interest in
recent years [15]–[20]. Counterfactual Regression Net [15] and
several other methods [18], [19] have been proposed to reduce
the discrepancy between the treated and untreated groups of
samples by learning a representation such that the two groups
are as close to each other as possible. However, their designs
are not capable of separating the covariates that only contribute
to the treatment assignment from those only contribute to the
outcomes. Furthermore, these methods are not able to infer
latent covariates from proxies.
Variable decomposition [9], [21] has been previously in-
vestigated for estimating the average treatment effect. In
[21] the variables are decomposed into confounding and risk
variables using optimization, and in [9] the confounder sets
are selected using Markov and Bayesian network algorithms.
Our method has several major differences from the above
methods: (i) our method is capable of estimating the individual
level heterogeneous treatment effects, where existing ones only
focus on the population level average treatment effect; (ii) we
are able to identify the non-linear relationships between the
latent factors and their proxies, whereas their approach only
models linear relationships; (iii) we can learn and disentangle
instrumental factors that affect only the treatment.
The work most related to ours is the Causal Effect Varia-
tional Autoencoder (CEVAE) [17], which also utilizes varia-
tional autoencoder to learn confounders from observed vari-
ables. However, CEVAE does not consider the existence of
non-confounders, and is not able to learn the separated sets
of instrumental and risk factors. As demonstrated by the
experiments, ignoring the existence of instrumental and risk
factors results in decreased estimation accuracy.
III. METHOD
A. Notations, Assumptions and Definitions
Let ti ∈ {0, 1} denote a binary treatment where ti = 0
indicates the i-th individual receives no treatment (control) and
ti = 1 indicates the individual receives the treatment (treated).
We use yi(1) to denote the potential outcome of i if it were
treated, and yi(0) to denote the potential outcome if it were
not treated. Noting that only one of the potential outcomes can
be realized, and the observed outcome is yi = (1− ti)yi(0)+
tiyi(1). Additionally, let xi ∈ Rd denote the “as is” set of
covariates for the i-th individual. When the context is clear,
we omit the subscript i in the notations.
Throughout the paper, we assume that the following three
fundamental assumptions necessary for data-driven treatment
effect estimation [5] are satisfied:
Assumption 1. (SUTVA) The Stable Unit Treatment Value
Assumption requires that the potential outcomes for one unit
(individual) is unaffected by the treatment of others.
Assumption 2. (Unconfoundedness) The distribution of treat-
ment is independent of the potential outcome when condition-
ing on the observed variables: t ⊥ (y(0), y(1))|x.
Assumption 3. (Overlap) Every unit has a non-zero proba-
bility to receive either treatment or control when given the
observed variables, i.e., 0 < P (t = 1|x) < 1.
An important goal of causal inference from observational
data is to evaluate the average treatment effect (ATE) and
conditional average treatment effect (CATE). The ATE is
defined as:
ATE = E[y(1)− y(0)] = E[y|do(t = 1)]− E[y|do(t = 0)], (1)
where do(t = 1) denote an manipulation on t by removing all
incoming edges to t setting its value to t = 1 [6].
The CATE for an individual i is defined as
τi = yi(1)− yi(0).
Due to the counterfactual problem, we never observe yi(1)
and yi(0) at the same time and thus τi is not observed for
any individual. Instead, we estimate the conditional average
treatment effect (τ(x)), which is defined as
τ(x) := E[τ |x] = E[y|x, do(t = 1)]− E[y|x, do(t = 0)], (2)
B. Treatment Effect Estimation from the Latent Factors
In this work, we propose the TEDVAE model diagram
(Figure 1) for estimating the treatment effects, where the
observed pre-treatment variables x can be viewed as generated
from three disjoint sets of latent factors z = (zt, zc, zy). Here
zt are the instrumental factors that only affect the treatment
but not the outcome, zy are the risk factors which only affect
the outcome but not the treatment, and zc are the confounding
factors that affect both the treatment and the outcome.
𝑦𝑡
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Fig. 2: Model diagram for treatment effect estimation using
confounders [22]. t is the treatment, y is the outcome. xc is the
confounding variables that must be included for adjustment.
It is the users responsibility to determine which variable in x
should be included or excluded from the adjustment set xc.
On the one hand, the proposed TEDVAE model in Figure 1
provides two important benefits. The first benefit is that, by ex-
plicitly modelling for the instrumental factors and adjustment
factors, it accounts for the fact that not all variables in the
observed variables set x are confounders. The second benefit
is that it allows for the possibility of learning unobserved
confounders that from their proxy variables.
On the other hand, it is important to note that our model
diagram does not pose any restriction other than the three
standard assumptions discussed in Section III (A). Indeed, the
widely used diagram for treatment effect estimation (Figure
2) can be viewed as a special case of our model. To see
this, consider the case where every variable in x itself is a
confounder, i.e., x = xc, then the generating mechanism in
the TEDVAE model becomes zc = x with zt = zy = ∅ and
the model in Figure 1 becomes identical to that of Figure 2.
With our causal structure, estimation of treatment effect is
immediate using the back-door criterion:
Theorem 1. The effect of t on y can be identified if we recover
the confounding factors zc from the data.
Proof. From Figure 1 we know that zt, zc are the parents of
the treatment t, following (3.13) in [6] we have,
P (y|do(t)) =
∑
zt
∑
zc
P (y|t, zt, zc)P (zt)P (zc). (3)
Utilizing the fact that y ⊥ zt|t, zc, we have
P (y|do(t)) =
∑
zt
P (zt)
∑
zc
P (y|t, zc)P (zc|t, zc, zt). (4)
Furthermore, since zc is not a descendant of t, by Markov
property we have t ⊥ zc|zc, zt. Therefore
P (y|do(t)) =
∑
zt
P (zt)
∑
zc
P (y|t, zc)P (zc|zc, zt). (5)
Note that
∑
zt
P (zt)P (zc|zt, zc) = P (zc), which gives us
P (y|do(t)) =
∑
zc
P (y|t, zc)P (zc).
For the estimation of the conditional average treatment
effect, our result follows from Theorem 3.4.1 in [6] as shown
in the following theorem:
Theorem 2. The conditional average treatment effect of t
on y conditioned on x can be identified if we recover the
confounding factors zc and risk factors zy .
Proof. Let Gt denote the causal structure obtained by remov-
ing all incoming edges of t in Figure 1, Gt denote the structure
by deleting all outgoing edges of t.
Noting that y ⊥ zt|t, zy, zc in Gt, using the three rules of
do-calculus we can remove zt from the conditioning set and
obtain
P (y|do(t),x) = P (y|do(t), zt, zc, zy) = P (y|do(t), zy, zc). (6)
Equation 5 use utilizes Rule 1. Furthermore, using Rule 2 with
(y ⊥ t|zc, zy) in Gt yields
P (y|do(t),x) = P (y|do(t), zy, zc) = P (y|t, zy, zc)
An implication of Theorem 1 and 2 is that they are not
restricted to binary treatment. In other words, our proposed
method can be used for estimating treatment effect of a
continuous treatment variable, while most of the existing
estimators are not able to do so. However, due to the lack
of datasets with continuous treatment variables for evaluating
this, we focus on the case of binary treatment variable and
leave the continuous treatment case for future work.
Theorems 1 and 2 suggest that disentangling the con-
founding factors allows us to exclude unnecessary factors
when estimating ATE and CATE. However, keen readers may
wonder since we already assumed unconfoundedness, doesn’t
straightforwardly adjusting for x achieve the same goal?
Theoretically, it has been shown that both the bias [4] and
the variance [8] of treatment effect estimation will increase if
variables unrelated to the outcome is included during the esti-
mation. Therefore, it is crucial to differentiate the instrumental,
confounding and risk factors and only use the appropriate
factors during treatment effect estimation. In the next section,
we propose our data-driven approach to learn and disentangle
the latent factors using a variational autoencoder.
C. Learning of the Disentangled Latent Factors
In the above discussion, we have seen that removing un-
necessary factors is crucial for efficient and accurate treatment
effect estimation. We have assumed that the mechanism which
generates the observed variables x from the latent factors
z and the decomposition of latent factors z = (zt, zc, zy)
are available. However, in practice both the mechanism and
the decomposition are not known. Therefore, the practical
approach would be to utilize the complete set of available
variables during the modelling to ensure the satisfaction of
the unconfoundedness assumption, and utilize a data-driven
approach to simultaneously learn and disentangle the latent
factors into disjoint subsets.
To this end, our goal is to learn the posterior distribution
p(z|x) for the set of latent factors with z = (zt, zy, zc) as
illustrated in Figure 1, where zt, zc, zy are independent of each
other and correspond the instrumental factors, confounding
factors, and risk factors, respectively. Because exact inference
would be intractable, we employ neural network based varia-
tional inference to approximate the posterior pθ(x|zt, zc, zy).
Specifically, we utilize three separate encoders qφt(zt|x),
qφc(zc|x), and qφy (zy|x) that serve as variational posteriors
over the latent factors. These latent factors are then used
by a single decoder pθ(x|zt, zc, zy) for the reconstruction
of x. Following standard VAE design, the prior distributions
p(zt), p(zc), p(zy) are chosen as Gaussian distributions [10].
Specifically, the factors and the generative models for x and
t are described as:
p(zt) =
Dzt∏
j=1
N (ztj |0, 1); p(zc) =
Dzc∏
j=1
N (zcj |0, 1);
p(zy) =
Dzy∏
j=1
N (zyj |0, 1); p(t|zt, zc) = Bern(σ(f1(zt, zc))
p(x|zt, zc, zy) =
d∏
j=1
p(xj |zt, zc, zy), (7)
with p(xj |zt, zc, zy) being the suitable distribution for the j-
th observed variable, f1 is a function parametrized by neural
network, and σ(·) being the logistic function, Dzt , Dzc , and
Dzy are the parameters that determine the dimensions of
instrumental, confounding, and risk factors to infer from x.
For continuous outcome variable y, we parametrize it as
using a Gaussian distribution with its mean and variance
given by a pair of disjoint neural networks that defines
p(y|t = 1, zc, zy) and p(y|t = 0, zc, zy). This pair of disjoint
networks allows for highly imbalanced treatment. Specifically,
for continuous y we parametrize its distribution as:
p(y|t, zc, zy) = N (µ = µˆ, σ2 = σˆ2);
µˆ = (tf2(zc, zy) + (1− t)f3(zc, zy)), (8)
σˆ2 = (tf4(zc, zy) + (1− t)f5(zc, zy)), (9)
where f2, f3, f4, f5 are neural networks parametrized by their
own parameters. The distribution for the binary outcome case
can be similarly parametrized with a Bernoulli distribution.
In the inference model, the variational approximations of
the posteriors are defined as:
qφt(zt|x) =
Dzt∏
j=1
N (µ = µˆt, σ2 = σˆ2t ); (10)
qφc(zc|x) =
Dzc∏
j=1
N (µ = µˆc, σ2 = σˆ2c );
qφy (zy|x) =
Dzy∏
j=1
N (µ = µˆy, σ2 = σˆ2y) (11)
where µˆt, µˆc, µˆy and σˆ2t , σˆ
2
c , σˆ
2
y are the means and variances
of the Gaussian distributions parametrized by neural networks
similarly to the µˆ and σˆ in the generative model.
Given the training samples, all of the parameters can be
optimized by maximizing the evidence lower bound (ELBO):
p(t|zt,zc)
p(zc) p(y|t=1,zc,zy)
p(y|t=0,zc,zy)
p(x|zt,zc,zy)
...
...
p(zy)
p(zt)
...
(a) Generative Model.
p(zy|x)
p(zt|x)
...
...
p(x)
...
p(zc|x)
p(t|x)
p(y|x)
(b) Inference Model.
Fig. 3: Overall architecture of the model network and the inference network for the Treatment Effect Disentangling Variational
AutoEncoder (TEDVAE). White nodes correspond to parametrized deterministic neural network transitions, gray nodes
correspond to drawing samples from the respective distribution and white circles correspond to switching paths according
to the treatment t. Dashed arrows in the inference model represent the two auxiliary classifiers qωt(t|zt, zc) and qωy (y|zy, zc).
LELBO(x, y, t) =Eqφcqφtqφy [log pθ(x|zt, zc, zy)]
−DKL(qφt(zt|x)||pθt(zt))
−DKL(qφc(zc|x)||pθc(zc))
−DKL(qφy (zy|x)||pθy (zy)). (12)
To encourage the disentanglement of the latent factors and
ensure that the treatment t can be predicted from zt and zc, and
the outcome y can be predicted from zy and zc, we add two
auxiliary classifier to the variational lower bound. Finally,the
objective of TEDVAE can be expressed as
LTEDVAE =LELBO(x, y, t)
+ αtEqφtqφc [log qωt(t|zt, zc)]
+ αyEqφy qφc [log qωy (y|t, zc, zy)], (13)
where αt and αy are the weights for the auxiliary objectives.
For predicting the CATEs of new subjects given their ob-
served covariates x, we use the encoders q(zy|x) and q(zc|x)
to sample the posteriors of the confounding and risk factors
for l times, and average over the predicted outcome y using
the auxiliary classifier qωy (y|t, zc, zy).
Apart from the fact that TEDVAE can differentiate the
instrumental, confounding and risk factors, another major dif-
ference between TEDVAE and CEVAE lies in their inference
models. During inference, CEVAE depends on t, x and y for
inferencing z; in other words, CEVAE needs to estimate p(t|x)
and p(y|t,x), inference z as p(z|t, y,x), and finally predict the
CATE as τˆ(x) = E[y|t = 1, z]−E[t|y = 0, z]. The estimations
of p(t|x) and p(y|t,x) are unnecessary since we assume that
t and y are the children of the latent factors and inferencing
the latents should only depend on x as in TEDVAE. As we
later show in the empirical study, this difference is crucial
even when there is no instrumental or risk factors and the
data follows exactly the model assumed in CEVAE.
Recently, it has been shown that unsupervised learning
of disentangled factors is impossible for generative models,
and constraints on the latent space are necessary to identify
a model that matches the underlying generating mechanism
[23]. TEDVAE avoids this problem by using the outcome
y and the treatment t along with x during model training.
Furthermore, the marginal distribution of z is forced to take the
decomposition qφ(z) = qφt(zt)qφc(zc)qφy (zy). The additional
information in y and t makes it possible for TEDVAE to learn
the disentangled latent factors.
An issue worth noting is that by employing variational
inference parameterized by neural networks, it cannot be guar-
anteed that the learned model is identical to the mechanism.
However, as demonstrated by the empirical evaluations, we
argue that variational autoencoder’s lack of theoretical support
is mitigated by its strong empirical performance and capability
of learning disentangled latent factors [24].
IV. EXPERIMENTS
We empirically compare the proposed algorithm with tradi-
tional and neural network based treatment effect estimators.
For traditional methods, we compare with tailor designed
methods including Squared t-statistic Tree (t-stats) [11] and
Causal Tree (CT) [1]; ensemble methods Causal Random
Forest (CRF) [14] and Bayesian Additive Regression Trees
(BART) [25]; meta learning algorithms X-Learner [13] using
Random Forest [26] as base learner (X-RF). For deep learning
based methods, we compare with representation learning based
methods including Counterfactual Regression Net (CFR) [15],
and Similarity Preserved Individual Treatment Effect (SITE)
[19], along with Causal Effect Variational Autoencoder (CE-
VAE) [17], a generative method which also utilizes the power
of VAE. For all compared algorithms, we use the implemen-
tation provided by the original authors on GitHub (for deep
learning algorithms) and on CRAN (for traditional methods).
Parameters for the compared methods are tuned by cross-
validated grid search on the value ranges recommended in
the code repository. We implemented TEDVAE using PyTorch
and the code with data has been made anonymously available
for reviewers at https://www.dropbox.com/s/qfzbruqkjotedxk/
TEDVAE.7z?dl=0.
A. Evaluation Criteria
For evaluating the performance of CATE estimation, we use
the Precision in Estimation of Heterogeneous Effect (PEHE)
[15], [17], [25], [27] which measures the root mean squared
distance between the estimated and the true CATE when
ground truth is available:
PEHE =
√√√√ 1
N
N∑
i=1
(τˆ(xi)− τ(xi))2 (14)
where τ(x) is the ground truth CATE for subjects with
observed variables xi.
For evaluating the performance of the average treatment
effect (ATE) estimation, the ground truth ATE can be cal-
culated by averaging the differences of the outcomes in the
treated and control groups if randomized controlled trials data
is available. Then, when comparing the ground truth ATE with
the estimated ATE obtained from a non-randomized sample
(observational sample or created via biased sampling) of the
dataset, the performances can then be evaluated using the mean
absolute error in ATE [15], [17], [19], [25] for evaluation:
ATE = |τˆ − 1
N
N∑
i=1
[tiyi − (1− ti)yi]|, (15)
where τˆ is the estimated ATE, ti and yi are the treatments and
outcomes from the randomized controlled trial data.
B. Parameter Tuning
Unlike parameter selection in standard supervised tasks
where models can be selected using cross-validation, a major
challenge of parameters tuning for treatment estimation is that
there is no ground truth CATE for any subject. Therefore,
the algorithm need to use some surrogate estimation τ˜i to
approximate the true treatment effect τi. A common approach
used by many existing methods [1], [21], [28] is to use the
matching surrogate: τ˜i = (2ti − 1)(yi − yjm(i)), where jm(i)
is the index of the nearest neighbor to the i-th individual xi
whose treatment is opposite to ti.
However, even with a moderate number of dimension, it is
unlikely that the matching surrogate would be a good choice
due to the curse of dimensionality. Another previously used
approach is to utilize a traditional estimator, e.g., BART as
a surrogate to provide an estimation of the true treatment
effect [18]. However, this approach is also not optimal as
it inevitably leads to a model that is similar to the chosen
surrogate estimator, and thus it is unlikely to produce models
better than the surrogate on a wide range of datasets.
We argue that a treatment effect estimation algorithm should
be self-sufficient and should not rely on other algorithms for
selecting parameters. Moreover, treatment effect algorithms
should be robust to the choice of parameters since the counter-
factual problem complicates the parameter tuning procedure.
To avoid the above problems, we simply use the validation
losses of TEDVAE for choosing parameters.
C. Evaluating the Identification of the Latent Factors
In order to investigate whether TEDVAE is able to learn
and disentangle the latent factors that generate the observed
variables, and utilize the learned factors for treatment effect
estimation, we conduce experiments using two different set-
tings to generate a variety of synthetic datasets.
Our first setting of synthetic datasets are generated using
the same procedure as in the CEVAE paper [17]. Specifically,
the marginal distribution of x is a mixture of Gaussians,
with a 5-dimensional hidden factor z determining the mixture
component:
z ∼ Bernoulli(0.5);
x|z ∼ N (z, θz1z+ θz0(1− z))
t|z ∼ Bernoulli(α · Sigmoid(ζ · z));
y|t, z ∼ Bernoulli(Sigmoid(β(ζ · z+ γ(2t− 1)))),
where θz1 and θz1 are integers randomly sampled from [1, 5],
ζ is a coefficient vector with the same dimension as z and the
coefficients are randomly sampled from (−1, 1). It can be seen
that α controls the proportion of treated samples, β controls
the size of the outcomes, and γ controls the scales of the
treatment effects. For the dimensions of latent factors, we set
the dimension of z (for CEVAE) to 5, and the dimensions of
zt, zc, zy (for TEDVAE) also to 5. All of the reported results
are obtained from averaging over 100 simulations where each
simulation contains 10,000 samples. The datasets are split into
60%/30%/10% of training/validation/test sets and results on
the test sets are reported.
We illustrate the results of this synthetic dataset in the first
row of Figure 4. It is worth noting that the data generating
procedure of this set of synthetic datasets matches exactly the
model assumption in CEVAE [17]. Therefore, it is reasonable
to expect that CEVAE would perform better than TEDVAE
under this setting, because the instrumental factors zt and
risk factors zy do not exist. However, from the first row of
Figure 4 we can see that TEDVAE either performs better
than CEVAE, or performs as well as CEVAE using a wide
range of parameters of this dataset. This is possibly due
to the differences in predicting for previous unseen samples
between TEDVAE and CEVAE, where CEVAE needs to follow
a complicated procedure of inferencing p(t|x) and p(y|t,x)
first and then inferencing the latents as p(z|t, y,x), whereas
in TEDVAE this is not needed. Considering the fact that we set
Dzt = Dzy = 5 for TEDVAE while there is no instrumental
or risk factors, these results suggests that the TEDVAE model
is able to effectively learn the latent factors and estimate the
CATE even when the instrumental and risk factors are absent.
It also indicates that the TEDVAE algorithm is robust to the
selection of the latent dimensionality parameters.
The second sets of synthetic datasets are generated from
three independent sets of 5-dimensional latent factors zt, zc,
and zy corresponding to the instrumental factors, confound-
ing factors, and the risk factors. Furthermore, the observed
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Fig. 4: Comparison of CEVAE and TEDVAE under different settings using the synthetic datasets. Rows: the results for data
generating procedure satisfies the assumption of the CEVAE model and the TEDVAE model, respectively. Columns: (Left)
Varying the proportional of treated samples controlled by α; (Middle) Varying the average size of the outcome controlled by
β; (Right) Varying the average size of the CATE controlled by γ. (Figures are best viewed in colour.)
covariates x is the concatenation of xc, xt, and xy generated
independently from each of the latent factors. Specifically,
zt ∼ Bern(0.5); zc ∼ Bern(0.5); zy ∼ Bern(0.5);
xt|zt ∼ N (zt, θzt1zt + θzt0 (1− zt));
xc|zc ∼ N (zc, θzc1zc + θzc0 (1− zc));
xy|zy ∼ N (zy, θzy1zy + θzy0 (1− zy));
t|zt, zy ∼ Bernoulli(α · Sigmoid(ζt · zt))
× Bernoulli(α · Sigmoid(ζzc1 · zc));
y|t, zy, zc ∼ N (β(ζzc2 · zc + γ(2t− 1)), 1)
+N (β(ζy · zy + γ(2t− 1)), 1),
where the θ and ζ are defined similarly as the first dataset. α,
β, and γ are parameters that control the proportion of treated
samples, size of the outcome, and size of the CATE. For
the dimensionality parameters, we set the dimension of z for
CEVAE to 15, and the dimensions of zt, zc, zy for TEDVAE
to 5. All of the reported results are obtained from averaging
over 100 simulations where each run contains 10,000 samples.
From the second row of Figure 4 we can clearly see
that when the data generating procedure matches the model
assumption of TEDVAE, the discrepancies between the PEHE
of TEDVAE and CEVAE is significant. When the proportions
of the treated samples varies, the performances of CEVAE
fluctuates severely and the error remains high even when
the dataset is balanced; however, the PEHEs of TEDVAE
are stable even when the dataset is highly imbalanced, and
are always stays significantly lower than CEVAE. When the
scales of outcome and CATE change, TEDVAE also performs
consistently and significantly better than CEVAE.
Next, we use the second set of synthetic datasets to in-
vestigate whether TEDVAE is capable of recovering the latent
factors of zt, zc, and zy that are used to generate the observed
covariates x. To do so, we compare the performances of
TEDVAE when setting the Dzt , Dzc and Dzy parameters to
10 against itself when setting one of the latent dimensionality
parameter of TEDVAE to 0, i.e., setting Dzt = 0 and forcing
TEDVAE to ignore the existence of zt. If TEDVAE is indeed
capable of recovering the latent factors, then its performances
with non-zero latent dimensionality parameters should be
better than its performance when ignoring the existence of
any of the latent factors.
Figure 5 illustrates the capability of TEDVAE for identi-
fying the latent factors using radar chart. Taking the Figure
5(a) as example, the zt and ¬zt polygons correspond to
the performances of TEDVAE when setting the dimension
parameter Dzt = 5 (identify zt) and Dzt = 0 (ignore zt).
From the figures we can clearly see that the performances of
TEDVAE are significantly better when the latent dimension-
ality parameters are set to non-zero, than setting any of the
latent dimensionality to 0.
D. Evaluating Estimation of Treatment Effects
In this section, we use two widely-used benchmark treat-
ment effect estimation datasets to compare TEDVAE with
state-of-the-arts using the PEHE metric (Equation 14).
1) Benchmark I: Atlantic Causal Inference Challenge:
The 2016 Atlantic Causal Inference Challenge (ACIC2016)
[27] contains 77 different settings of benchmark datasets
that are designed to test causal inference algorithms under
a diverse range of real-world scenarios. The datasets are
constructed on the basis of the Collaborative Perinatal Project
[29], a longitudinal study which was conducted on pregnant
women and their children between 1959 to 1974 designed for
discovering causal factors related to developmental disorders.
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Fig. 5: Radar charts that visualize the capability of TEDVAE in identifying the latent factors. Each vertex on the polygons is
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TABLE I: Means and standard deviations of the PEHE metrics
(smaller is better) for training and test sets on the 77 bench-
mark datasets from ACIC2016. The bolded values indicate the
best performers (Wilcoxon signed rank tests at p = 0.05).
Methods trPEHE 
te
PEHE
CT 4.81±0.18 4.96±0.21
t-stats 5.18±0.18 5.44±0.20
CF 2.16±0.17 2.18±0.19
BART 2.13±0.18 2.17±0.15
X-RF 1.86±0.15 1.89±0.16
CFR 2.05±0.18 2.18±0.20
SITE 2.32±0.19 2.41±0.23
CEVAE 3.12±0.28 3.28±0.35
TEDVAE 1.87±0.13 1.89±0.15
The dataset contains 4802 observations and 58 variables. The
challenge organizers then generate the outcome and treatment
variables using different data generating procedures for the 77
settings, simulating a wide range of different linear/non-linear
relationships between treatment effects and the covariate,
proportions of treated subjects, overlap of the treatment group,
magnitudes of the treatment effect, and magnitudes of the
treatment effect heterogeneities. This dataset can be accessed
at https://github.com/vdorie/aciccomp/tree/master/2016.
We conduct parameter tuning using the only first of the
77 settings and applied the same set of parameters to all
other settings, instead of tuning the parameters separately for
the 77 settings. This approach has two benefits: firstly and
most importantly, if an algorithm performs well using the
same parameters across all 77 settings, it indicates that the
algorithm is not sensitive to the choice of parameters and
thus would be easier for practitioners to use in real-world
scenarios; the second benefit is to save computation costs,
as conducting parameter tuning across a large amount of
datasets can be computationally overwhelming for practition-
ers. As a result, we set the latent dimensionality parameters as
Dzt = Dzy = 10, Dzc = 20 and set the weight for auxiliary
losses as αt = αy = 100 for all of the 77 settings. For
all the parametrized neural networks, we use 4 hidden layers
and 500 hidden neurons in each layer, with ELU activation.
The results reported are the average PEHE metric across 77
settings, where each setting is repeated for 10 replications with
a 60%/30%/10% train/validation/test splitting proportions.
The results on the ACIC2016 datasets are reported in
Table I. Firstly, we can see that the top-2 performers are
TEDVAE and X-RF. After conducting paired t-tests at the
significant level of p = 0.05, we find that the win/tie/loss
counts of TEDVAE versus X-RF are 38/4/35. To determine if
one of the two top performers are significantly better than
the other, we conduct Wilcoxon signed rank tests and the
result indicates that the performances of TEDVAE and X-
RF are not significantly different with p = 0.41. For other
compared methods excluding X-RF, the results indicate that
the performances of TEDVAE are significantly better. These
results show that, without tuning parameters individually for
each setting, TEDVAE already achieves state-of-the-art per-
formances across diverse range of data generating procedures,
which empirically demonstrates that TEDVAE is effective for
treatment effect estimation across different settings.
2) Benchmark II: Infant Health Development Program:
The Infant Health and Development Program (IHDP) dataset is
a randomized controlled study designed to evaluate the effect
of home visit from specialist doctors on the cognitive test
scores of premature infants. The program is a randomized
controlled trial which began in 1985, and the targets of the
program are low-birth-weight, premature infants. Subjects in
the treatment group are provided with intensive high-quality
child care and home visits from a trained health-care provider.
The program was effective at improving the cognitive func-
tions of the treated subjects when compared with the control
subjects where the average treatment effect (ATE) on all the
subjects from this dataset is reported as 4.
The IHDP dataset is first used for benchmarking treatment
TABLE II: Means and standard deviations of the PEHE metric
(smaller is better) training and test subjects on Settings A and
B of the IHDP datasets. The bolded values indicate the best
performers (Wilcoxon signed rank tests (p = 0.05).
Setting A Setting B
Methods trPEHE 
te
PEHE 
tr
PEHE 
te
PEHE
CT 1.48±0.12 1.56±0.13 5.46±0.08 5.73±0.09
t-stats 1.78±0.09 1.91±0.12 5.40±0.08 5.71±0.09
CF 1.01±0.08 1.09±0.16 3.86±0.05 3.91±0.07
BART 0.87±0.07 0.88±0.07 2.78±0.03 2.91±0.04
X-RF 0.98±0.08 1.09±0.15 3.50±0.04 3.59±0.06
CFR 0.67±0.02 0.73±0.04 2.60±0.04 2.76±0.04
SITE 0.65±0.07 0.67±0.06 2.65±0.04 2.87±0.05
CEVAE 0.95±0.12 1.04±0.14 2.90±0.10 3.24±0.12
TEDVAE 0.62±0.11 0.63±0.12 2.10±0.09 2.22±0.08
effect estimation algorithms in [25], where selection bias is
induced by removing a non-random subset of the treated
subjects to create an observational dataset, and the outcomes
are simulated using the original covariates and treatments. The
dataset contains 747 subjects and 25 variables that describe
both the characteristics of the infants and the characteristics of
their mothers. We use the same procedure as described in [25]
which includes two settings of this benchmark: ‘Setting A” and
“Setting B”, where the outcomes follow a linear relationship
with the variables in “etting A” and an exponential relationship
in “Setting B”. The code for generating this dataset can
be accessed at https://github.com/vdorie/npci. The reported
performances are calculated by averaging over 100 replications
for each of the settings with a training/validation/test splits
proportions of 60%/30%/10%.
We argue that a good treatment effect estimation algorithm
should perform reasonably well across a wide range of datasets
with minimum requirement for parameter tuning. Therefore,
for TEDVAE we use exactly the same parameters as in
the ACIC2016 dataset. In other words, we do not perform
parameter tuning for TEDVAE on the IHDP benchmarks.
For the compared traditional methods, we also use the same
parameters as selected on the ACIC2016 benchmark. For the
compared deep learning methods, we conducted grid search
for the parameters using the recommended parameter ranges
in the relevant papers.
From Table II we can see that TEDVAE clearly achieves
the lowest PEHE errors among the compared methods on both
Setting A and Setting B of the IHDP benchmark. Wilcoxon
signed rank tests (p = 0.05) indicate that TEDVAE is
significantly better than the compared methods. Considering
the fact that TEDVAE uses exactly the same parameters as in
the ACIC2016 benchmarks, these results demonstrate that the
TEDVAE model is applicable to diverse real-world scenarios
and is robust to the choice of parameters.
3) Real-world datasets: Jobs and Twins: In this section, we
use two real-world randomized trial datasets to compare the
methods capability of estimating the average treatment effects.
The Jobs dataset is based on the randomized controlled trial
originally provided in [30], which has then become a widely
used benchmark for average treatment effect estimation. The
TABLE III: Means and standard deviations of ATE on the
Jobs and Twins datasets. The bolded values indicate the best
performers (Wilcoxon signed rank tests (p = 0.05).
Jobs Twins
Methods trATE 
te
ATE 
tr
ATE 
te
ATE
CT 0.448±0.005 0.448±0.005 0.034±0.002 0.038±0.007
t-stats 0.448±0.004 0.448±0.005 0.032±0.003 0.033±0.005
CF 0.064±0.000 0.064±0.000 0.025±0.001 0.025±0.001
BART 0.064±0.001 0.064±0.001 0.050±0.002 0.051±0.002
X-RF 0.064±0.001 0.064±0.001 0.075±0.003 0.074±0.004
CFR 0.116±0.028 0.120±0.032 0.029±0.002 0.030±0.002
SITE 0.134±0.031 0.142±0.050 0.031±0.003 0.033±0.003
CEVAE 0.265±0.078 0.284±0.079 0.046±0.020 0.047±0.021
TEDVAE 0.064±0.000 0.064±0.000 0.006±0.002 0.006±0.002
treatment is whether a subject has participated in a job training
program, and the outcome is the subject’s employment status.
This dataset combines the original randomized controlled
trial samples, the Panel Study of Income Dynamics (PSID)
observational samples, and the Current Population Survey
(CPS) samples. The randomized controlled trial samples allow
for the estimation of the true average treatment effect, and
by including the observational samples we can investigate
whether the algorithms can account for the confounding bias
in the observational data. As a result, the dataset includes
19,204 samples where each sample is described by 8 covariates
including age, education, and previous earnings of the partic-
ipants, etc. We follow the procedure in [15] to use a binary
outcome variable indicating whether the program is effective
for improving the participant’s income.
The Twins dataset has been previously used for evaluating
causal inference in [17], [19]. It consists of samples from twin
births in the U.S. between the year of 1989 and 1991 provided
in [31]. Each subject is described by 40 variables related to the
parents, the pregnancy and the birth statistics of the twins. The
treatment is considered as t = 1 if a sample is the heavier one
of the twins, and considered as t = 0 if the sample is lighter.
The outcome is a binary variable indicating the children’s
mortality after a one year follow-up period. Following the
procedure in [19], we remove the subjects that are born with
weight heavier than 2,000g and those with missing values, and
introduced selection bias by removing a non-random subset of
the subjects. The final dataset contains 4,813 samples. The data
splitting is the same as previous experiments, and the reported
results are averaged over 100 replications.
The ATE estimation performances are illustrated in Table
III. On the Twins dataset, TEDVAE is the clear winner of all
compared algorithms. On the Jobs dataset, the performances
of the top performers including TEDVAE, CF, BART, X-RF
are not significantly different from each other, but performs
better than the rest of the compared methods.
Overall, the experiments results show that the performances
of TEDVAE are either significantly better than the compared
methods, or are similar to the best performers on a wide range
of datasets. In the meantime, none of the compared methods
performs as consistently as the performance of TEDVAE.
Additionally, the results also indicate that TEDVAE is less
sensitive to the choice of parameters than the other deep
learning based methods, which makes our method attractive
for real-world application scenarios.
V. CONCLUSION AND FUTURE WORK
In this work, we tackle the treatment effect estimation
problem in the wild where the observed variables may con-
tain noisy proxy variables of hidden confounders and non-
confounders. We argued that most of the previous methods
can be improved in two aspects. Firstly, they take the observed
variables as is and do not consider the fact that many of
them are not true confounders. Secondly, they do not consider
the fact that some difficult to measure confounders may be
represented by proxy variables. Based on our model diagram
which assumes that the observed variables are generated from
three disjoint sets of latent factors including the confounding,
the instrumental and the risk factors, we propose the Treat-
ment Effect Disentangled Variational AutoEncoder (TEDVAE)
algorithm to jointly learn and disentangle three disjoints sets
of latent factors from the observed variables. Experimental
results on a wide range of synthetic, benchmark, and real-
world datasets verified the practical usefulness of our method.
For future work, a path worth exploring is extending the
TEDVAE model to estimating treatment effects with non-
binary treatment variables. This is important because the
treatment often involves different level of dosages in many
applications. Unfortunately, most of the existing methods are
restricted to binary treatment and cannot be extended to non-
binary cases. The generative model of TEDVAE makes it a
promising candidate for this line of research.
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